NCT03867305

Brief Summary

We hypothesize that the use of MOBIDERM® after total knee prosthesis allows a greater and faster resorption of periarticular edema:

  • improvement of knee flexion;
  • faster functional gain;
  • faster decrease in postoperative pain by decreasing tissue tension.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 6, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 7, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

July 26, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 3, 2022

Completed
Last Updated

February 11, 2022

Status Verified

February 1, 2022

Enrollment Period

2.4 years

First QC Date

March 6, 2019

Last Update Submit

February 10, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Knee volume

    unit: mm3

    Day -1

  • Knee volume

    unit: mm3

    Day 0

  • Knee volume

    unit: mm3

    Day 1

  • Knee volume

    unit: mm3

    Day 5

  • Knee volume

    unit: mm3

    Day 15

  • Knee volume

    unit: mm3

    Month 1

Secondary Outcomes (25)

  • visual analog pain scale visual analog pain scale

    Day 1

  • visual analog pain scale visual analog pain scale

    Day 3

  • visual analog pain scale visual analog pain scale

    Day 5

  • visual analog pain scale visual analog pain scale

    Day 15

  • visual analog pain scale visual analog pain scale

    Month 1

  • +20 more secondary outcomes

Study Arms (2)

MOBIDERM group

EXPERIMENTAL
Device: MOBIDERM

Control group

NO INTERVENTION

Interventions

MOBIDERMDEVICE

Use of a MOBIDERM mobilizing band after total knee prosthesis

MOBIDERM group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient requiring a first total knee prosthesis (scheduled between Tuesday and Friday).
  • Patient that has given his/her free and informed consent and signed the consent form.
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient is at least 18 years old (≥) and under 90 years old (\<).

You may not qualify if:

  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • The patient is pregnant or breastfeeding
  • The patient is allergic to latex bandages.
  • The subject has contralateral amputation, pressure ulcers, severe Obstructive Arteriopathy of Lower Limbs, lymphoedema or thromboembolic event of the lower limb (ipsilateral and / or contralateral / superficial or deep or detected by postoperative Doppler).
  • The subject has chronic or active wounds or any cause that hinders normal rehabilitation or the application of a bandage.
  • patient with a stroke / Disabling Neurological Pathology, Chronic Immunological Pathology / Systemic Disease.
  • patient with Hepatic insufficiency.
  • patient with Venous insufficiency (stages 3 and 4).
  • The patient is on dialysis.
  • The subject has cognitive or behavioral disorders (Parkinson's disease, cerebellar syndrome, opposition, agitation, dementia).
  • The subject has a history of knee surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nîmes University Hospital

Nîmes, 30029, France

Location

MeSH Terms

Conditions

Edema

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 6, 2019

First Posted

March 7, 2019

Study Start

July 26, 2019

Primary Completion

December 14, 2021

Study Completion

February 3, 2022

Last Updated

February 11, 2022

Record last verified: 2022-02

Locations